MedPath

Comparison of Transcutaneous Auricular Vagus and Trigeminal Nerve Stimulation

Not Applicable
Completed
Conditions
Autonomic Nervous System Imbalance
Registration Number
NCT06730165
Lead Sponsor
Bahçeşehir University
Brief Summary

The aim of this study was to compare the results between transcutaneous auricular vagus nerve stimulation and trigeminal nerve stimulation with the results obtained from heart rate variability, pulse and blood pressure measurements and to reveal which method is more effective in autonomic nervous system neuromodulation.

Hypotheses of the study:

H0: Vagus nerve stimulation is more effective than trigeminal nerve simulation in terms of heart rate variability.

H1: Trigeminal nerve stimulation is more effective than vagus nerve simulation in terms of heart rate variability.

Detailed Description

In this study, 80 healthy participants (40 males, 40 females) aged between 20-50 years were randomized (www.randomizer.org) into four groups by computer software. After randomisation, one group was received transcutaneous vagus nerve stimulation inside the ear, while the other group was received trigeminal nerve stimulation above the ear.The third group received sham transcutaneous vagus nerve stimulation and the fourth group received sham trigeminal nerve simulation. Heart rate variability, pulse rate and blood pressure measurements were performed to determine which stimulation method is more effective. Heart rate variability was analysed with Kubios HRV programme after the 5-minute short measurement method. SNS, PNS and Stress Index and LF, HF and LF/HF parameters were evaluated in heart rate variability sub-parameters.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • To be 18 years of age or older,
  • Not having any acute or chronic disease.
Exclusion Criteria
  • Having any acute or chronic disease,
  • Having previously undergone vagus nerve stimulation or trigeminal nerve stimulation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Heart Rate VariabilityPre-intervention and immediately after the intervention

5 minutes of heart rate variability was measured.

Secondary Outcome Measures
NameTimeMethod
Systolic and Diastolic Blood PressurePre-intervention and immediately after the intervention

Systolic and diastolic blood pressure was measured with an electronic blood pressure monitor.

Trial Locations

Locations (1)

Avrasya University

🇹🇷

Trabzon, Ortahisar, Turkey

© Copyright 2025. All Rights Reserved by MedPath